アジア太平洋の皮膚科治療薬市場予測2019-2028

◆英語タイトル:ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET FORECAST 2019-2028
◆商品コード:INK20AG103
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年7月
◆ページ数:125
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:アジア太平洋
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥131,250見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥157,500見積依頼/購入/質問フォーム
Enterprisewide PriceUSD2,000 ⇒換算¥210,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

KEY FINDINGSThe Asia Pacific dermatological therapeutics market is projected to record a CAGR of 7.96% during the forecast period, 2019-2028. The rising disposable income and the surging number of skin disorders are estimated to be instrumental factors for market growth.

MARKET INSIGHTS
The Asia Pacific dermatological therapeutics market growth evaluation encompasses the analysis of Japan, India, China, Indonesia, South Korea, Vietnam, Thailand, Australia & New Zealand, and the rest of Asia Pacific. Japan has a continuously growing geriatric population. The nation is also ranked among the top when it comes to the rising senior population in the Asia Pacific. Such a steep increase means a rise in the need for frequent services, thereby becoming a potential customer base for dermatological procedures. The country is also among the high-income countries of the Asia Pacific. The rising burden of skin diseases in the countries entails impetigo, warts, acne, atopic dermatitis, etc. Of these, atopic dermatitis was regarded as the most common skin-related disease in the country, as per the National Health and Wellness Survey. In India, there is an increasing demand for new healthcare technological advancements to meet the surging burden of skin diseases. Though WHO states that the developing countries suffer due to poor infrastructure and minimum healthcare facilities, the government initiatives in India are evaluated to be beneficial for market growth. Thus, factors like global warming, rising awareness with regard to personal hygiene, and the increasing aging population, are set to stimulate the growth of the Indian market.

COMPETITIVE INSIGHTS
Some of the leading companies present in the market are, Merck KGaA, Leo Pharma A/S, Novartis AG, AGI Dermatics, Pfizer Inc, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. RISING LOAD OF DERMATOLOGY DISEASES
3.2.2. RISE IN AWARENESS LEVELS OF DISEASE PROGRESSION AND ORIGIN
3.3. KEY RESTRAINTS
3.3.1. SEVERE SIDE EFFECTS OF CERTAIN CLASSES OF THERAPEUTIC DRUGS
4. KEY ANALYTICS
4.1. KEY INVESTMENT INSIGHTS
4.2. PORTER’S FIVE FORCE ANALYSIS
4.2.1. BUYER POWER
4.2.2. SUPPLIER POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. OPPORTUNITY MATRIX
4.4. VENDOR LANDSCAPE
5. MARKET BY DRUG CLASS
5.1. ANTI-INFECTIVES
5.2. CORTICOSTEROIDS
5.3. ANTI-ACNE
5.4. CALCINEURIN INHIBITORS
5.5. RETINOIDS
5.6. OTHER DRUG CLASSES
6. MARKET BY APPLICATION
6.1. ALOPECIA
6.2. HERPES
6.3. PSORIASIS
6.4. ROSACEA
6.5. ATOPIC DERMATITIS
6.6. ACNE VULGARIS
6.7. OTHER APPLICATIONS
7. GEOGRAPHICAL ANALYSIS
7.1. ASIA PACIFIC
7.1.1. CHINA
7.1.2. JAPAN
7.1.3. INDIA
7.1.4. SOUTH KOREA
7.1.5. INDONESIA
7.1.6. THAILAND
7.1.7. VIETNAM
7.1.8. AUSTRALIA & NEW ZEALAND
7.1.9. REST OF ASIA PACIFIC
8. COMPANY PROFILES
8.1. ABBVIE INC
8.2. ALLERGAN INC
8.3. ALMIRAL
8.4. AMGEN INC
8.5. BAUSCH HEALTH COMPANIES INC
8.6. GALDERMA
8.7. GLAXOSMITHKLINE PLC
8.8. JOHNSON & JOHNSON
8.9. NOVARTIS AG
8.10. PFIZER INC
8.11. AGI DERMATICS
8.12. LEO PHARMA A/S
8.13. MERCK KGAA

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - DERMATOLOGICAL THERAPEUTICS
TABLE 2: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 3: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 4: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 5: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY, APPLICATION, FORECAST YEARS, 2019-2028 (IN $ BILLION)
TABLE 6: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ BILLION)
TABLE 7: ASIA PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ BILLION)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[アジア太平洋の皮膚科治療薬市場予測2019-2028]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆